These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2170286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L, Floch A, Mondot S, Cavero I.
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [Abstract] [Full Text] [Related]

  • 3. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L, Floch A, Cavero I.
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [Abstract] [Full Text] [Related]

  • 4. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
    Hwang SB, Lam MH, Hsu AH.
    Mol Pharmacol; 1989 Jan; 35(1):48-58. PubMed ID: 2536468
    [Abstract] [Full Text] [Related]

  • 5. PAF binding to a single receptor in corneal epithelium plasma membrane.
    Hurst J, Ma X, Bazan HE.
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):790-5. PubMed ID: 10067986
    [Abstract] [Full Text] [Related]

  • 6. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O, Robaut C, Cavero I.
    J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
    [Abstract] [Full Text] [Related]

  • 7. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X.
    Int J Tissue React; 1985 Feb; 7(5):339-43. PubMed ID: 2997065
    [Abstract] [Full Text] [Related]

  • 8. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Szalkowski DM, MacIntyre DE, Bach TJ, Luell S, Meuer R, Sahoo SP, Alberts AW, Chabala JC.
    J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC, Seldon PM, Barnes PJ, Giembycz MA.
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [Abstract] [Full Text] [Related]

  • 10. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Alberts AW, Bugianesi RL, Chabala JC, Ponpipom MM.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449
    [Abstract] [Full Text] [Related]

  • 11. Characterization of platelet-activating factor receptors on canine T lymphocytes.
    Mangino MJ, Murphy MK, Weiss A, Anderson CB.
    J Immunol; 1993 Nov 15; 151(10):5310-8. PubMed ID: 8228226
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
    Ortega MP, García MC, Gijón MA, de Casa-Juana MF, Priego JG, Sanchez Crespo M, Sunkel C.
    J Pharmacol Exp Ther; 1990 Oct 15; 255(1):28-33. PubMed ID: 2170624
    [Abstract] [Full Text] [Related]

  • 15. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
    Chen J, Giri SN.
    J Pharmacol Exp Ther; 1997 Jun 15; 281(3):1047-58. PubMed ID: 9190835
    [Abstract] [Full Text] [Related]

  • 16. Chemical and biochemical characterization of lignan analogs as novel PAF receptor antagonists.
    Shen TY.
    Lipids; 1991 Dec 15; 26(12):1154-6. PubMed ID: 1668110
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ, O'Neill C.
    Lipids; 1991 Dec 15; 26(12):1189-92. PubMed ID: 1668116
    [Abstract] [Full Text] [Related]

  • 20. Identification of platelet-activating factor receptors in P388D1 murine macrophages.
    Valone FH.
    J Immunol; 1988 Apr 01; 140(7):2389-94. PubMed ID: 2832476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.